This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Zacks.com featured highlights include Devon Energy, Marathon Oil, Everest Group, Stride and American Woodmark
by Zacks Equity Research
Devon Energy, Marathon Oil, Everest Group, Stride and American Woodmark are part of the Zacks Screen of the Week article.
Buy These 4 Low-Beta Stocks to Counter Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Granite Ridge (GRNT), Ardmore Shipping (ASC), McKesson (MCK) and Stride (LRN) are well-poised to gain.
Is K12 (LRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
K12 (LRN) possesses solid growth attributes, which could help it handily outperform the market.
LRN vs. LOPE: Which Stock Is the Better Value Option?
by Zacks Equity Research
LRN vs. LOPE: Which Stock Is the Better Value Option?
Stride, Inc. (LRN) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
K12 (LRN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Attractive PEG-Based GARP Stocks for Investors
by Urmimala Biswas
Here are five PEG-based GARP stocks that qualify our screening criteria - DVN, MRO, EG, LRN and AMWD.
3 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like GES, CEG and LRN that are seeing price strength have a high chance of carrying the momentum forward.
K12 (LRN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
K12 (LRN) delivered earnings and revenue surprises of 128.21% and 5.25%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights Stride, Deckers Outdoor, Molina Healthcare and McKesson
by Zacks Equity Research
Stride, Deckers Outdoor, Molina Healthcare and McKesson have been highlighted in this Screen of The Week article.
K12 (LRN) Upgraded to Buy: Here's Why
by Zacks Equity Research
K12 (LRN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are Consumer Discretionary Stocks Lagging American Woodmark (AMWD) This Year?
by Zacks Equity Research
Here is how American Woodmark (AMWD) and K12 (LRN) have performed compared to their sector so far this year.
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. LRN, DECK, MOH and MCK and are sound enough to meet financial obligations.
Stride's (LRN) MedCerts Partners With University of Vermont
by Zacks Equity Research
Intending to increase the number of skilled medical professionals in Vermont, Stride's (LRN) company MedCerts collaborates with UVM PACE to bring MedCerts healthcare training programs to the state's working adults.
Stride (LRN) Unveils New Content Options With Wonder Media
by Zacks Equity Research
Stride (LRN) to fulfill its commitment to deliver an engaging, standards-aligned curriculum for K-12 students.
Is Stride (LRN) Stock Outpacing Its Consumer Discretionary Peers This Year?
by Zacks Equity Research
Here is how K12 (LRN) and Panasonic Corp. (PCRFY) have performed compared to their sector so far this year.
Stride (LRN) Q4 Earnings & Revenues Top Estimates, Shares Up
by Zacks Equity Research
Stride's (LRN) fiscal fourth-quarter 2023 results reflect growth in Career Learning enrollment demand as well as revenue per enrollment.
Stride's (LRN) MedCerts Partners With GW University Hospital
by Zacks Equity Research
Stride's (LRN) subsidiary unit MedCerts collaborates with The GW University Hospital, boosting career opportunities in healthcare.
Best Growth Stocks to Buy for June 26th
by Zacks Equity Research
ENS, LRN and VRT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 26, 2023.
Best Growth Stocks to Buy for June 23rd
by Zacks Equity Research
CCU, LRN and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 23, 2023.
Best Growth Stocks to Buy for June 21st
by Zacks Equity Research
LRN, PERI and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 21, 2023.
Best Growth Stocks to Buy for June 20th
by Zacks Equity Research
PHM, LRN and GPK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 20, 2023.
Draftkings (DKNG) Improves Bid for PointsBet's US Business
by Zacks Equity Research
DraftKings (DKNG) submits an improved offer to acquire PointsBet's US operations for $195 million.
Stride's (LRN) MedCerts Unveils Healthcare Courses via Coursera
by Zacks Equity Research
Stride's (LRN) MedCerts joins Coursera for its healthcare courses and expands its reach.
Best Growth Stocks to Buy for June 15th
by Zacks Equity Research
LRN, VRT and GPK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 15, 2023.
Stride's (LRN) Unit MedCerts Collaborates With Mason Center
by Zacks Equity Research
Stride's (LRN) MedCerts enters into a healthcare education partnership with Mason Center to broaden opportunities in Tennessee.